A study led by University of British Columbia and Vancouver Coastal Health Research Institute researchers has revealed how the fatal neurodegenerative disease amyotrophic lateral sclerosis (ALS), also known as Lou Gehrig's ...
Feb 18, 2014
0
0
Promising new research by Christian Mueller, Ph.D., and Robert H. Brown Jr., DPhil, MD, at the University of Massachusetts Medical School, provides evidence that a therapy using synthetic microRNAs may safely treat patients ...
Oct 31, 2018
0
118
A tiny sliver of a person's DNA—several thousand times smaller than a typical gene—produces a molecule that has crucial influence over whether a person has any control over their muscles, according to a paper published ...
Dec 17, 2015
0
84
For the first time, scientists have revealed a mechanism underlying the cellular degeneration of upper motor neurons, a small group of neurons in the brain recently shown to play a major role in ALS pathology.
Jan 28, 2015
0
132
Evaluating the effectiveness of therapies for neurodegenerative diseases is often difficult because each patient's progression is different. A new study shows artificial intelligence (AI) analysis of blood samples can predict ...
Jan 28, 2020
0
173
Participation in recreational activities—including golfing, gardening or yard work, woodworking, and hunting—may be associated with an increase in a person's risk for developing amyotrophic lateral sclerosis, or ALS, ...
Mar 13, 2024
0
9
A speech prosthetic developed by a collaborative team of Duke neuroscientists, neurosurgeons, and engineers can translate a person's brain signals into what they're trying to say.
Nov 6, 2023
0
27
Our movements are controlled by multiple neural pathways that connect the brain and spinal cord. In particular, neurons in the cerebral cortex send commands to the motor neurons in the spinal cord and then to the muscles, ...
Aug 18, 2023
1
67
Researchers at Karolinska Institutet in Sweden have developed a stem cell-based model to study the resilience and vulnerability of neurons in the neurodegenerative disease ALS. The results are published in the journal Stem ...
May 10, 2019
0
10
Prilenia Therapeutics B.V., a clinical stage biotechnology company focused on the urgent mission to develop novel therapeutics to slow the progression of neurodegenerative and neurodevelopmental disorders, today announced ...
May 25, 2022
0
85
